Joshua Parks Sasine MD PhD

PubMed

• 3 citations
  Outcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL.
  Gregory W Roloff, Ibrahim Aldoss, Noam E Kopmar, Chenyu Lin, Simone E Dekker
  Journal of Clinical Oncology. 2025-02-10
• 2 citations
  Impact of prior inotuzumab ozogamicin treatment on brexucabtagene autoleucel outcomes in adults with B-cell ALL.
  Ibrahim Aldoss, Gregory W Roloff, Rawan Faramand, Noam E Kopmar, Chenyu Lin
  Blood Advances. 2024-12-10
• Epidermal growth factor augments the self-renewal capacity of aged hematopoietic stem cells.
  Vivian Y Chang, Yuwei He, Samantha Grohe, Morgan R Brady, Aldi Chan
  Iscience. 2024-07-19

Abstracts/Posters

• Tisagenlecleucel Chimeric Antigen Receptor (CAR) T-Cell Therapy for Adults with Diffuse Large B-Cell Lymphoma (DLBCL): Real World Experience from the Center for Intern...
  Joshua Sasine, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Granulocyte Colony-Stimulating Factor (G-CSF) Interactions with Chimeric Antigen Receptor (CAR) T-Cell Therapy for Diffuse Large B-Cell Lymphoma
  Joshua Sasine, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

• Inhibition of Semaphorin 3A Signaling Promotes Regeneration of Hematopoietic Stem Cells and Their Bone Marrow Vascular Niche 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018